IGFBP6 and pulmonary arterial hypertension: IGFBP-6 likely contributes to PAH through effects on vascular smooth muscle proliferation, inflammation, and fibrosis, though evidence is indirect. Elevated levels in atherosclerosis suggest potential relevance. and It may represent an early-stage biomarker/target pending further validation